Jason Briggeman
Jason Briggeman publishes mostly in Economics and Econometrics, Management of Technology and Innovation and Sociology and Political Science, on topics such as Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Intellectual Property and Patents.
- World rank
- #5,204,967 of 7,710,434 ranked researchers
- Rank in United States
- #1,335,401 of 1,627,098
- Works
- 17
- Citations
- 33
- Citations per work
- 1.9
What does Jason Briggeman research?
Jason Briggeman's work is mostly in Economics, Econometrics and Finance (39%), Business, Management and Accounting (6%), Social Sciences (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences1056.4%
- Everything else635.0%
- Life Sciences14.3%
- Health Sciences14.3%
- Medicine14.3%
- 1Economics and Econometrics39% of their works
- 2Management of Technology and Innovation6% of their works
- 3Sociology and Political Science6% of their works
- 4Physiology4% of their works
- 5History and Philosophy of Science4% of their works
- 6Pharmacology4% of their works
Research topics
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Intellectual Property and Patents
- Economic Theory and Institutions
- Pharmaceutical industry and healthcare
- Biomedical Ethics and Regulation
- Experimental Behavioral Economics Studies
- Biosimilars and Bioanalytical Methods
Which keywords describe Jason Briggeman's research?
The keywords of their largest research topics: Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Clinical Trials, Cost-effectiveness Analysis, Quality of Life, Economic Institutions and Institutional Economics.
- Immunogenicity
- Stem Cell Regulation
- Research Outcome
- Economic Experiments
- Patent Analysis
- Institutional Economics
- Quality of Life
- Clinical Trials
- Drug Development Costs
- Pharmaceutical Industry
- Generic Drugs
- Cost-effectiveness Analysis
- Economic Institutions
- Intellectual Property Rights
- Conflict of Interest
- Regulatory Challenges
- Social Preferences
- Biosimilars
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Pharmaceutical Industry92 topics
- Drug Development Costs71 topic
- Generic Drugs71 topic
- Clinical Trials42 topics
- Cost-effectiveness Analysis41 topic
- Quality of Life41 topic
- Economic Institutions31 topic
- Institutional Economics31 topic
- Intellectual Property Rights31 topic
- Patent Analysis31 topic
- Conflict of Interest21 topic
- Economic Experiments21 topic
- Regulatory Challenges21 topic
- Research Outcome21 topic
- Social Preferences21 topic
- Stem Cell Regulation21 topic
- Biosimilars11 topic
- Immunogenicity11 topic
Where does Jason Briggeman work?
Jason Briggeman's main affiliation in the publication record is Austin Community College, United States.
How many publications and citations does Jason Briggeman have?
OpenAlex counts 17 works and 33 citations for Jason Briggeman, an h-index of 3, ranking #5,204,967 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jason Briggeman. Posts are plain text and can be reported.